American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -408 | -108 | -276 | -900 | -712 |
| Depreciation Amortization | 273 | 184 | 94 | 378 | 283 |
| Accounts receivable | -457 | -614 | -419 | 305 | 165 |
| Accounts payable and accrued liabilities | -89 | 100 | 20 | -766 | -631 |
| Other Working Capital | -182 | -186 | -293 | 717 | 415 |
| Other Operating Activity | 540 | 503 | 402 | 520 | 477 |
| Operating Cash Flow | $-323 | $-121 | $-472 | $254 | $-3 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -57 | -10 | -6 | -35 | -28 |
| Investing Cash Flow | $-57 | $-10 | $-6 | $-35 | $-28 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 488 | 223 | 518 | -171 | 148 |
| Debt Repayment | -77 | -48 | -19 | -145 | -96 |
| Other Financing Activity | 0 | 0 | 0 | -69 | -41 |
| Financing Cash Flow | $411 | $175 | $499 | $-385 | $11 |
| Beginning Cash Position | 35 | 35 | 35 | 201 | 201 |
| End Cash Position | 66 | 79 | 56 | 35 | 181 |
| Net Cash Flow | $31 | $44 | $21 | $-166 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -323 | -121 | -472 | 254 | -3 |
| Capital Expenditure | -57 | -10 | -6 | -35 | -28 |
| Free Cash Flow | -380 | -131 | -478 | 219 | -31 |